Cash flow aXichem AB

Stocks

AXIC A

SE0005250719

Specialty Chemicals

Delayed Nasdaq Stockholm 13:42:29 19/08/2026 +04			5-day change	1st Jan Change
2.900 ^SEK	+0.69%		-2.68%	+40.10%

07-24	AXichem's Salmonella-inhibiting Chicken Feed Additive Gets EU Agency Backing	MT
06-26	AXichem Receives Order for Feed Additives for SEK4.2 Million	MT

ac6bf3e05.yEiKqEiE3VqS9dNARvHyE4YB_fcuuLYJLbffMgEuHQs.iinS4ArWt2PVmJowIYu-JbZxp4d-wPJDGoeIZEcfR3OnDNLlfdzrHOOClg

Published financial data: AXICHEM AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.36M	5.01M	1.81M	8.57M	18.45M
Total Revenues	4.36M	5.01M	1.81M	8.57M	18.45M
Cost of Goods Sold, Total	3.45M	1.19M	400K	1.49M	9.36M
Gross Profit	909K	3.82M	1.41M	7.08M	9.08M
Selling General & Admin Expenses, Total	12.97M	14.76M	15.54M	18.15M	21.12M
Depreciation & Amortization - (IS)	2.47M	3.51M	3.83M	4.28M	4.9M
Other Operating Expenses	534K	91K	-642K	485K	560K
Other Operating Expenses, Total	15.98M	18.36M	18.73M	22.91M	26.57M
Operating Income	-15.07M	-14.54M	-17.32M	-15.83M	-17.49M
Interest Expense, Total	-2K	-2.69M	-3.47M	-1.96M	-118K
Interest And Investment Income	14K	-	-	-	-
Net Interest Expenses	12K	-2.69M	-3.47M	-1.96M	-118K
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
EBT, Excl. Unusual Items	-15.06M	-17.24M	-20.79M	-17.78M	-17.61M
EBT, Incl. Unusual Items	-15.06M	-17.24M	-20.79M	-17.78M	-17.61M
Income Tax Expense	35K	25K	25K	32K	27K
Earnings From Continuing Operations	-15.09M	-17.26M	-20.81M	-17.82M	-17.64M
Net Income to Company	-15.09M	-17.26M	-20.81M	-17.82M	-17.64M
Minority Interest	-	3K	3K	2K	3K
Net Income - (IS)	-15.09M	-17.26M	-20.81M	-17.81M	-17.63M
Net Income to Common Incl Extra Items	-15.09M	-17.26M	-20.81M	-17.81M	-17.63M
Net Income to Common Excl. Extra Items	-15.09M	-17.26M	-20.81M	-17.81M	-17.63M
Per Share Items
Net EPS - Basic	-0.92	-1.04	-1.03	-0.46	-0.3
Basic EPS - Continuing Operations	-0.92	-1.04	-1.03	-0.46	-0.3
Basic Weighted Average Shares Outstanding	16.34M	16.54M	20.3M	38.53M	59.11M
Net EPS - Diluted	-0.92	-1.04	-1.03	-0.46	-0.3
Diluted EPS - Continuing Operations	-0.92	-1.04	-1.03	-0.46	-0.3
Diluted Weighted Average Shares Outstanding	16.34M	16.54M	20.3M	38.53M	59.11M
Normalized Basic EPS	-0.58	-0.65	-0.64	-0.29	-0.19
Normalized Diluted EPS	-0.58	-0.65	-0.64	-0.29	-0.19
Supplemental Items
EBITDA	-13.51M	-12.44M	-15.1M	-13.48M	-15.02M
EBITA	-13.54M	-12.48M	-15.13M	-13.5M	-15.02M
EBIT	-15.07M	-14.54M	-17.32M	-15.83M	-17.49M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	4.44M	5.22M	2.68M	8.96M	19.04M
Effective Tax Rate - (Ratio)	-0.23	-0.14	-0.12	-0.18	-0.15
Total Current Taxes	35K	25K	25K	32K	27K
Normalized Net Income	-9.41M	-10.77M	-12.99M	-11.11M	-11M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	910K	1.4M	1.62M	1.93M	2.42M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	9.45M	6.55M	4.31M	14.36M	3.08M
Total Cash And Short Term Investments	9.45M	6.55M	4.31M	14.36M	3.08M
Accounts Receivable, Total	2.45M	5.11M	3.54M	5.22M	3.55M
Other Receivables	300K	272K	175K	297K	198K
Total Receivables	2.75M	5.38M	3.72M	5.51M	3.75M
Inventory	2.59M	6.08M	8.82M	7.76M	7.94M
Prepaid Expenses	357K	518K	642K	436K	347K
Total Current Assets	15.14M	18.53M	17.5M	28.07M	15.12M
Gross Property Plant And Equipment	205K	205K	205K	205K	205K
Accumulated Depreciation	-112K	-153K	-178K	-194K	-202K
Net Property Plant And Equipment	93K	52K	27K	11K	3K
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	27.76M	27.54M	27.14M	26.21M	25.75M
Deferred Charges Long-Term	15.77M	15.13M	16.83M	19.99M	20.22M
Total Assets	58.77M	61.25M	61.49M	74.28M	61.1M
Liabilities
Accounts Payable, Total	1.25M	798K	1.13M	2.33M	1.33M
Accrued Expenses, Total	830K	857K	1.13M	1.32M	1.76M
Short-term Borrowings	-	18.76M	10.27M	-	4.73M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Income Taxes Payable	-	25K	25K	32K	27K
Other Current Liabilities	-	486K	413K	443K	378K
Total Current Liabilities	2.08M	20.92M	12.96M	4.12M	8.22M
Long-Term Debt	-	-	-	-	-
Other Non Current Liabilities	390K	-	-	-	-
Total Liabilities	2.47M	20.92M	12.96M	4.12M	8.22M
Common Stock, Total	3.31M	3.31M	4.3M	11.82M	11.82M
Additional Paid In Capital	145M	146M	175M	206M	207M
Retained Earnings	-15.09M	-17.26M	-20.81M	-17.81M	-17.63M
Comprehensive Income and Other	-77.12M	-92.23M	-110M	-130M	-148M
Total Common Equity	56.3M	40.31M	48.5M	70.13M	52.86M
Minority Interest	-	21K	22K	24K	21K
Total Equity	56.3M	40.33M	48.53M	70.16M	52.88M
Total Liabilities And Equity	58.77M	61.25M	61.49M	74.28M	61.1M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.54M	16.54M	40.31M	59.11M	59.11M
ECS Total Common Shares Outstanding	16.54M	16.54M	21.5M	59.11M	59.11M
Book Value / Share	3.4	2.44	2.26	1.19	0.89
Tangible Book Value	28.54M	12.76M	21.37M	43.92M	27.1M
Tangible Book Value Per Share	1.73	0.77	0.99	0.74	0.46
Total Debt	0	18.76M	10.27M	0	4.73M
Net Debt	-9.45M	12.21M	5.96M	-14.36M	1.64M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	21K	22K	24K	21K
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	4.99M	7.34M	6.27M	6.21M
Inventories - Finished Goods, Total	-	-	1.48M	1.49M	1.73M
Inventories - Others	-	1.09M	-	-	-
Machinery, Total	205K	205K	205K	205K	205K
Full Time Employees	6	6	7	7	7

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-15.09M	-17.26M	-20.81M	-17.81M	-17.63M
Depreciation & Amortization - CF	39K	41K	25K	16K	8K
Amortization of Goodwill and Intangible Assets - (CF)	1.52M	2.07M	2.19M	2.33M	2.47M
Depreciation & Amortization, Total	1.56M	2.11M	2.22M	2.35M	2.48M
Amortization of Deferred Charges, Total - (CF)	910K	1.4M	1.62M	1.93M	2.42M
Other Operating Activities, Total	54K	1.29M	1.57M	1.24M	465K
Change In Accounts Receivable	-2.14M	-2.79M	2.05M	-1.59M	1.84M
Change In Inventories	-1.21M	-3.49M	-2.74M	1.07M	-181K
Change In Accounts Payable	-	-	-	-	-
Change in Other Net Operating Assets	319K	-360K	431K	1.32M	-737K
Cash from Operations	-15.6M	-19.1M	-15.68M	-11.5M	-11.35M
Capital Expenditure	-16K	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-4.71M	-2.61M	-5.1M	-6.5M	-4.66M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-4.73M	-2.61M	-5.1M	-6.5M	-4.66M
Short Term Debt Issued, Total	-	18.8M	-	-	4.73M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	18.8M	-	-	4.73M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	17.74M	-	28.54M	38.65M	-
Other Financing Activities, Total	-	-	-10M	-10.59M	-
Cash from Financing	17.74M	18.8M	18.54M	28.05M	4.73M
Foreign Exchange Rate Adjustments	6K	1K	-3K	-1K	-2K
Net Change in Cash	-2.58M	-2.9M	-2.24M	10.05M	-11.28M
Supplemental Items
Cash Interest Paid	2K	1.64M	2.37M	1.2M	118K
Cash Income Tax Paid (Refund)	-	35K	25K	32K	27K
Levered Free Cash Flow	-14.72M	-16.46M	-14.94M	-12.43M	-9.73M
Unlevered Free Cash Flow	-14.72M	-14.78M	-12.77M	-11.21M	-9.65M
Change In Net Working Capital	3.05M	6.59M	681K	-909K	-1.04M
Net Debt Issued / Repaid	-	18.8M	-	-	4.73M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-16.45	-15.15	-17.64	-14.57	-16.15
Return on Total Capital	-17.13	-15.76	-18.36	-15.34	-17.11
Return On Equity %	-27.45	-35.73	-46.85	-30.02	-28.67
Return on Common Equity	-27.45	-35.73	-46.87	-30.03	-28.67
Margin Analysis
Gross Profit Margin %	20.84	76.25	77.89	82.63	49.23
SG&A Margin	297.36	294.81	858.76	211.74	114.47
EBITDA Margin %	-309.63	-248.39	-834.88	-157.29	-81.4
EBITA Margin %	-310.52	-249.21	-836.26	-157.48	-81.44
EBIT Margin %	-345.48	-290.49	-957.32	-184.68	-94.82
Income From Continuing Operations Margin %	-346.01	-344.72	-1.15K	-207.88	-95.61
Net Income Margin %	-346.01	-344.66	-1.15K	-207.85	-95.59
Net Avail. For Common Margin %	-346.01	-344.66	-1.15K	-207.85	-95.59
Normalized Net Income Margin	-215.76	-215.08	-718.08	-129.67	-59.65
Levered Free Cash Flow Margin	-337.46	-328.8	-826.04	-145.02	-52.74
Unlevered Free Cash Flow Margin	-337.43	-295.22	-706.12	-130.76	-52.34
Asset Turnover
Asset Turnover	0.08	0.08	0.03	0.13	0.27
Fixed Assets Turnover	41.74	69.06	45.8	451.05	2.64K
Receivables Turnover (Average Receivables)	3.45	1.33	0.42	1.96	4.21
Inventory Turnover (Average Inventory)	1.74	0.27	0.05	0.18	1.19
Short Term Liquidity
Current Ratio	7.27	0.89	1.35	6.8	1.84
Quick Ratio	5.85	0.57	0.62	4.82	0.83
Operating Cash Flow to Current Liabilities	-7.48	-0.91	-1.21	-2.79	-1.38
Days Sales Outstanding (Average Receivables)	105.89	275.3	872.75	187.08	86.74
Days Outstanding Inventory (Average Inventory)	209.35	1.33K	6.8K	2.04K	305.93
Average Days Payable Outstanding	90.78	79.97	111.97	1.5K	69.84
Cash Conversion Cycle (Average Days)	224.46	1.53K	7.56K	729.69	322.83
Long Term Solvency
Total Debt/Equity	-	46.51	21.16	-	8.94
Total Debt / Total Capital	-	31.75	17.46	-	8.21
LT Debt/Equity	-	-	-	-	-
Long-Term Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	4.21	34.16	21.08	5.55	13.45
EBIT / Interest Expense	-7.54K	-5.41	-4.99	-8.09	-148.23
EBITDA / Interest Expense	-6.75K	-4.62	-4.35	-6.89	-127.25
(EBITDA - Capex) / Interest Expense	-6.76K	-4.62	-4.35	-6.89	-127.25
Total Debt / EBITDA	-	-1.51	-0.68	-	-0.31
Net Debt / EBITDA	0.7	-0.98	-0.39	1.07	-0.11
Total Debt / (EBITDA - Capex)	-	-1.51	-0.68	-	-0.31
Net Debt / (EBITDA - Capex)	0.7	-0.98	-0.39	1.07	-0.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	255.5	14.79	-63.87	373.74	115.24
Gross Profit, 1 Yr. Growth %	52.52	320.02	-63.1	402.56	28.24
EBITDA, 1 Yr. Growth %	12.44	-7.92	21.44	-10.75	11.39
EBITA, 1 Yr. Growth %	12.45	-7.88	21.24	-10.79	11.31
EBIT, 1 Yr. Growth %	11.52	-3.48	19.06	-8.61	10.51
Earnings From Cont. Operations, 1 Yr. Growth %	11.68	14.36	20.59	-14.41	-1
Net Income, 1 Yr. Growth %	11.68	14.34	20.59	-14.41	-1.01
Normalized Net Income, 1 Yr. Growth %	11.43	14.43	20.63	-14.46	-0.99
Diluted EPS Before Extra, 1 Yr. Growth %	8.92	12.95	-1.31	-55.12	-35.1
Accounts Receivable, 1 Yr. Growth %	2.81K	108.66	-30.57	47.14	-31.92
Inventory, 1 Yr. Growth %	88.28	135.06	45.12	-12.08	2.33
Net Property, Plant and Equip., 1 Yr. Growth %	-19.83	-44.09	-48.08	-59.26	-72.73
Total Assets, 1 Yr. Growth %	5.43	4.22	0.39	20.8	-17.75
Tangible Book Value, 1 Yr. Growth %	10.81	-55.28	67.43	105.54	-38.29
Common Equity, 1 Yr. Growth %	4.94	-28.41	20.34	44.59	-24.64
Cash From Operations, 1 Yr. Growth %	33.36	22.46	-17.91	-26.62	-1.36
Capital Expenditures, 1 Yr. Growth %	-52.94	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	3.73	14.88	-9.23	-16.83	-21.73
Unlevered Free Cash Flow, 1 Yr. Growth %	3.73	3.16	-13.58	-12.27	-13.85
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	256.61	102.01	-35.6	30.83	219.32
Gross Profit, 2 Yr. CAGR %	389.09	153.1	24.5	36.18	153.87
EBITDA, 2 Yr. CAGR %	10.45	1.75	5.75	4.11	-0.29
EBITA, 2 Yr. CAGR %	10.49	1.78	5.68	4	-0.35
EBIT, 2 Yr. CAGR %	10.12	3.75	7.2	4.31	0.5
Earnings From Cont. Operations, 2 Yr. CAGR %	9.68	13.01	17.43	1.6	-7.95
Net Income, 2 Yr. CAGR %	9.68	13	17.42	1.6	-7.95
Normalized Net Income, 2 Yr. CAGR %	9.56	12.92	17.49	1.58	-7.97
Diluted EPS Before Extra, 2 Yr. CAGR %	8.02	10.92	5.58	-33.45	-46.03
Accounts Receivable, 2 Yr. CAGR %	165.17	679.65	20.36	1.07	0.08
Inventory, 2 Yr. CAGR %	60.36	110.38	84.7	12.96	-5.15
Net Property, Plant and Equip., 2 Yr. CAGR %	-10.07	-33.05	-46.12	-54.01	-66.67
Total Assets, 2 Yr. CAGR %	-7.74	4.82	2.29	10.13	-0.32
Tangible Book Value, 2 Yr. CAGR %	-14.45	-29.6	-13.47	85.51	12.62
Common Equity, 2 Yr. CAGR %	-8.45	-13.32	-7.18	31.91	4.39
Cash From Operations, 2 Yr. CAGR %	13.27	27.79	0.26	-22.39	-14.93
Capital Expenditures, 2 Yr. CAGR %	-49.6	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	14.29	7.71	2.12	-13.11	-19.32
Unlevered Free Cash Flow, 2 Yr. CAGR %	14.66	2.06	-5.58	-12.93	-13.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	133.19	144.4	13.81	25.25	54.45
Gross Profit, 3 Yr. CAGR %	91.22	364.89	33.22	98.23	33.48
EBITDA, 3 Yr. CAGR %	15.79	3.95	7.93	-0.06	6.48
EBITA, 3 Yr. CAGR %	15.83	3.99	7.89	-0.12	6.38
EBIT, 3 Yr. CAGR %	15.95	5.39	8.62	1.65	6.34
Earnings From Cont. Operations, 3 Yr. CAGR %	14.99	11.22	15.48	5.68	0.72
Net Income, 3 Yr. CAGR %	14.99	11.21	15.48	5.68	0.72
Normalized Net Income, 3 Yr. CAGR %	14.9	11.16	15.43	5.69	0.72
Diluted EPS Before Extra, 3 Yr. CAGR %	11.54	9.64	6.68	-20.61	-34
Accounts Receivable, 3 Yr. CAGR %	-	144.81	248.16	28.7	-11.4
Inventory, 3 Yr. CAGR %	236.33	82.16	85.88	44.21	9.3
Net Property, Plant and Equip., 3 Yr. CAGR %	6.96	-23.25	-38.49	-50.91	-61.36
Total Assets, 3 Yr. CAGR %	15.2	-3.91	3.32	8.12	-0.08
Tangible Book Value, 3 Yr. CAGR %	170.55	-31.08	-6.03	15.46	28.54
Common Equity, 3 Yr. CAGR %	24.61	-15.65	-3.3	7.6	9.46
Cash From Operations, 3 Yr. CAGR %	27.86	16.25	10.26	-9.65	-15.93
Capital Expenditures, 3 Yr. CAGR %	-44.18	-	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	27.36	13.47	1.74	-4.63	-16.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	28.23	9.7	-3.44	-7.87	-13.24
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	39.37	90.34	71.95
Gross Profit, 5 Yr. CAGR %	-	-	61.06	184.49	72.42
EBITDA, 5 Yr. CAGR %	-	-	11.66	4.01	4.56
EBITA, 5 Yr. CAGR %	17.98	11.69	11.66	3.99	4.52
EBIT, 5 Yr. CAGR %	20.52	15.16	12.37	4.96	5.3
Earnings From Cont. Operations, 5 Yr. CAGR %	19.97	18.54	15.96	7.26	5.47
Net Income, 5 Yr. CAGR %	19.97	18.53	15.96	7.26	5.46
Normalized Net Income, 5 Yr. CAGR %	19.92	18.5	15.93	7.23	5.43
Diluted EPS Before Extra, 5 Yr. CAGR %	7.45	15.94	9.12	-10.2	-18.77
Accounts Receivable, 5 Yr. CAGR %	-	-	-	71.85	111.45
Inventory, 5 Yr. CAGR %	79.71	132.25	164.63	50.47	42.03
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-18.7	-37.46	-51.86
Total Assets, 5 Yr. CAGR %	4.57	9.7	9.85	1.47	1.85
Tangible Book Value, 5 Yr. CAGR %	10.98	10.75	71.48	2.41	1.03
Common Equity, 5 Yr. CAGR %	6.38	3.55	10.76	0.87	-0.3
Cash From Operations, 5 Yr. CAGR %	23.06	19.96	16.01	-1.1	-0.6
Levered Free Cash Flow, 5 Yr. CAGR %	-9.95	15.27	15.97	1.98	-7.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	-9.88	12.48	12.84	0.02	-7.41